Evidence map›Paper›PMID 36425066›Full record

ArticleFrontiers in genetics2022

Suppression of endogenous retroviral enhancers in mouse embryos derived from somatic cell nuclear transfer.

Daiki Shikata, Shogo Matoba, Masashi Hada, Akihiko Sakashita, Kimiko Inoue, Atsuo Ogura

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Daiki ShikataBioresource Engineering Division, RIKEN BioResource Research Center, Tsukuba, Ibaraki, Japan.
Shogo MatobaBioresource Engineering Division, RIKEN BioResource Research Center, Tsukuba, Ibaraki, Japan.
Masashi HadaBioresource Engineering Division, RIKEN BioResource Research Center, Tsukuba, Ibaraki, Japan.
Akihiko SakashitaDepartment of Molecular Biology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Kimiko InoueBioresource Engineering Division, RIKEN BioResource Research Center, Tsukuba, Ibaraki, Japan.
Atsuo OguraBioresource Engineering Division, RIKEN BioResource Research Center, Tsukuba, Ibaraki, Japan.
RIKEN BioResource Research Center · JPKeio University · JPThe University of Tokyo · JPTokyo University of Agriculture and Technology · JPUniversity of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endogenous retroviruses (ERVs) in the mammalian genome play diverse roles in embryonic development. These developmentally related ERVs are generally repressed in somatic cells and therefore are likely repressed in embryos derived from somatic cell nuclear transfer (SCNT). In this study, we sought to identify ERVs that are repressed in SCNT-derived morulae, which might cause previously unexplained embryonic deaths shortly after implantation. Our transcriptome analysis revealed that, amongst ERV families, ERVK was specifically, and strongly downregulated in SCNT-derived embryos while other transposable elements including LINE and ERVL were unchanged. Among the subfamilies of ERVK, RLTR45-int was most repressed in SCNT-derived embryos despite its highest expression in control fertilized embryos. Interestingly, the nearby genes (within 5-50 kb,

Indexed as

endogenous retrovirusenhancerepigeneticsRNA sequencingsomatic cell nuclear transfer

Identifiers

PMID36425066
PMCPMC9681155
OpenAlexW4308460185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.